Shah Vinay 4/A
4/A · Virpax Pharmaceuticals, Inc. · Filed Aug 16, 2023
Insider Transaction Report
Form 4/AAmended
Shah Vinay
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-06-20+100,000→ 100,000 totalExercise: $0.99From: 2024-06-20Exp: 2033-06-20→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest after 12 months of continuous service, and the remaining 75% of the shares subject to the Option will vest in equal monthly installments over the next 24 months of continuous service